picolinic acid: Clinical Trials

20 trials of picolinic acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 2 terminated, 1 active not recruiting, 1 not yet recruiting. 8 Not applicable, 5 Phase 4, 4 Phase 2, 3 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 7, Not yet recruiting 1
Phase 45Completed 3, Active not recruiting 1, Unknown 1
Phase 24Completed 2, Recruiting 1, Terminated 1
Phase 13Completed 2, Terminated 1
Early Phase 11Completed 1

Follow picolinic acid: new trials by email Literature Review of picolinic acid trials Research Report on picolinic acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Chromium Weight Reduction on Adult Asthma Control
Chromium picolinate - Asthma Chronic, Bronchial Asthma
Not applicableNot yet recruitingCairo University602026-08-202026-07-14
BPPV Recurrence After CRM With & Without Supplementation
Combined vitamin D₃ and K₂ supplementation, Vitamin D₃ alone, Canalith repositioning maneuver (CRM) alone - Benign Paroxismal Positional Vertigo
Early Phase 1CompletedUniversity of Jordan4042025-01-012026-10-06
Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance
Chromium picolinate, Placebo matching Chromium Picolinate - Insulin Resistance, Acanthosis Nigricans
Not applicableCompletedUruk University902025-01-012026-02-23
Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection
Chromium - Sacro Iliac Joint Pain, Diabetes
Phase 4Active not recruitingFayoum University602024-06-032024-11-29
Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning
Circadian Rhythms for Mood (CRM) application - Active, Circadian Rhythms for Mood (CRM) application - Sham - Major Depressive Disorder, Bipolar 1 Disorder
Not applicableCompletedHucircadian932022-05-272025-03-17
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
Zinc Picolinate, Resveratrol, Zinc Picolinate Placebo - Covid19, SARS-CoV Infection
Phase 2TerminatedSwedish Medical Center452020-09-082022-07-29
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
Zinc Picolinate 15 Mg - DNA Damage, Immune System Disorder
Phase 2RecruitingUniversity of New Mexico1002019-05-192026-06-04
The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β
Zinc, Nifedipine, Beta Carotene - PreTerm Birth
Phase 4CompletedUniversitas Indonesia562017-01-012017-11-21
The Effect of β-Carotene, Vitamin D3 and Zinc on Hyaline Membrane Disease and Feeding Intolerance in Premature Neonates
Beta carotene, Vitamin D3, Zinc - Hyaline Membrane Disease, Necrotizing Enterocolitis of Newborn
Phase 4UnknownUniversitas Indonesia1202017-01-012018-08-13
Binge Eating and Chromium Study
Sugar Pill, chromium picolinate - Binge Eating Disorder
Phase 1 / Phase 2CompletedUniversity of North Carolina, Chapel Hill262008-07-012012-04-03
Chromium's Effect on Insulin Resistance in Obesity
chromium picolinate - Insulin Resistance, Obesity
Not applicableCompletedStony Brook University402007-04-012011-08-12
Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes
Chromium Picolinate - Type 2 Diabetes
Phase 1TerminatedBastyr University402006-01-012007-10-31
Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults
chromium picolinate - Insulin Resistance, HIV Infections
Phase 1 / Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)392005-11-012016-03-23
Novel Therapy for Glucose Intolerance in HIV Disease
Chromium Picolinate - Insulin Resistance
CompletedStony Brook University472005-06-012013-12-10
Effects of Chromium Picolinate on Food Intake
Chromium Picolinate - Obesity, Atypical Depression
Not applicableCompletedPennington Biomedical Research Center422005-04-012016-02-12
Chromium Picolinate for the Treatment of Metabolic Syndrome
Chromium picolinate - Metabolic Syndrome X, Prediabetic State
Not applicableCompletedNational Center for Complementary and Integrative Health (NCCIH)602004-01-012006-08-18
A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM
Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg) - Diabetes Mellitus, Type 2
Not applicableCompletedNutrition 21, Inc.402003-11-012006-03-29
Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes
chromium picolinate 1000 mcg daily vs placebo, Placebo - Type 2 Diabetes
Phase 4CompletedPennington Biomedical Research Center1002003-10-012016-04-08
Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM
Chromium Picolinate (600 mcg Cr) + biotin (2 mg) - Diabetes Mellitus, Type 2
Not applicableCompletedNutrition 21, Inc.6002003-03-012006-02-09
Chromium and Insulin Action
Chromium Picolinate - Type 2 Diabetes
Phase 4CompletedPennington Biomedical Research Center301998-08-012016-04-08

Conditions studied

Insulin Resistance (7)  ·  Diabetes Mellitus, Type 2 (5)  ·  Obesity (3)  ·  Acanthosis Nigricans (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Asthma (1)  ·  Binge-Eating Disorder (1)  ·  Bipolar Disorder (1)  ·  Body Weight (1)  ·  Bulimia (1)  ·  COVID-19 (1)  ·  Depressive Disorder, Major (1)  ·  Diabetes Mellitus (1)  ·  HIV Infections (1)  ·  Hyaline Membrane Disease (1)

Sponsors

Pennington Biomedical Research Center (3)  ·  National Center for Complementary and Integrative Health (NCCIH) (2)  ·  Nutrition 21, Inc. (2)  ·  Stony Brook University (2)  ·  Universitas Indonesia (2)  ·  Bastyr University (1)  ·  Cairo University (1)  ·  Fayoum University (1)  ·  Hucircadian (1)  ·  Swedish Medical Center (1)  ·  University of Jordan (1)  ·  University of New Mexico (1)  ·  University of North Carolina, Chapel Hill (1)  ·  Uruk University (1)

Countries

United States (11)  ·  Egypt (1)  ·  Indonesia (1)  ·  Iraq (1)  ·  Jordan (1)  ·  South Korea (1)

Top investigators

William Cefalu, MD (2)  ·  Atef M Sayed, MD (1)  ·  Cesar Albarracin, MD (1)  ·  Ghasak Kais Abdulhussain, BSc, MSc, PhD (Pharmacology) (1)  ·  Hank Kaplan, MD (1)  ·  Jeffery Geohas, MD (1)  ·  Kimberly A Brownley, PhD (1)  ·  Manley R Finch (1)  ·  Marie C Gelato, MD, PhD (1)  ·  Marie C. Gelato, MD, PhD (1)  ·  Mohamed A Hamed, MD (1)  ·  Nayyar Iqbal, MD (1)  ·  Ryan Bradley, ND (1)  ·  Stephen D Anton, Ph.D. (1)  ·  Yuyun Lisnawati (1)

Results publications

PMID 17684468, PMID 19422140, PMID 20022616, PMID 23751236, PMID 25346863, PMID 29307520, PMID 39086163